Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry
Open Access
- 1 May 2011
- journal article
- Published by Springer Science and Business Media LLC in Clinical Research in Cardiology
- Vol. 100 (10), 897-905
- https://doi.org/10.1007/s00392-011-0320-5
Abstract
Background In contrast to surveys in cardiologist settings, presentation and management of atrial fibrillation (AF) in primary care patients is less well studied. Methods and results The prospective ATRIUM (Outpatient Registry Upon Morbidity of Atrial Fibrillation) collected data from patients with AF seen by 730 physicians representing a random sample of all primary care physicians in Germany. ATRIUM enrolled 3,667 patients (mean age, 72 ± 9 years; 58% male, mean CHADS2 score 2.2 ± 1.3), 994 (27.1%) with paroxysmal, 944 (25.7%) with persistent or long-standing persistent and 1,525 (41.6%) with permanent AF (no AF type was specified in 204 patients). Mean duration since initial diagnosis of AF was 61 ± 66 months (median 42, interquartile range 14–88). Reported symptoms included palpitations (43%), shortness of breath (49%), fatigue (49%), dizziness (37%) and angina (20%). Most common concomitant conditions were hypertension (84%), heart failure (43%), coronary artery disease (345%), diabetes (35%) and chronic kidney disease (20%). Prior myocardial infarction was present in 11% of patients, prior stroke in 10% and prior transient ischemic attack in 10%. Antithrombotic medication was used by 93% of the patients (oral anticoagulants, 83%). Rate control therapy was reported in 75% and rhythm control therapy in 33%, often added to rate control. Drugs for rhythm and rate control included ß-blockers (75%), calcium antagonists (15%), digitalis (29%), sodium channel blockers of type IA (quinidine, 1.0%) or IC (flecainide or propafenone, 5%), and potassium channel blockers including amiodarone (11%). In the year prior to enrollment, 46% of the patients had been cardioverted (23% by drugs, 22% electrically), catheter ablation had been performed in 5%, and 10% received a pacemaker or defibrillator. A high proportion (44%) of the patients were hospitalized in the year prior to enrollment. Conclusions Patients with AF managed in primary care often receive guideline-conforming therapy including antithrombotic therapy, rate control and rhythm control (numbers given above). Despite this apparent adherence, almost half of the patients were hospitalized in the year prior to enrollment, suggesting that the therapies applied do not stabilize patients sufficiently to keep them out of hospital.Keywords
This publication has 40 references indexed in Scilit:
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Lenient versus Strict Rate Control in Patients with Atrial FibrillationThe New England Journal of Medicine, 2010
- The RecordAF Study: Design, Baseline Data, and Profile of Patients According to Chosen Treatment Strategy for Atrial FibrillationThe American Journal of Cardiology, 2010
- The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial managementEP Europace, 2008
- Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or FlutterThe New England Journal of Medicine, 2007
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationThe New England Journal of Medicine, 2002
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationThe New England Journal of Medicine, 2002
- The canadian registry of atrial fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillationThe American Journal of Cardiology, 1998
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimatesThe American Journal of Cardiology, 1998
- Cardioversion of atrial fibrillation in the elderlyThe American Journal of Cardiology, 1996